Literature DB >> 8057494

Mutation of the bovine papillomavirus E5 oncoprotein at amino acid 17 generates both high- and low-transforming variants.

J Sparkowski1, J Anders, R Schlegel.   

Abstract

The E5 transforming protein of bovine papillomavirus type 1 is a 44-amino-acid, hydrophobic protein which localizes predominantly to Golgi membranes. The E5 transmembrane domain contains a highly conserved glutamine residue at position 17 which, from previous limited mutagenic analysis, appeared essential for transforming activity. In order to determine the specific amino acid requirements at this position, we constructed a series of substitution mutants, representing all classes of amino acids, employing a vector which expressed E5 independently of other bovine papillomavirus gene products. All of the expressed E5 mutant proteins were stable, dimerized normally, and localized to the Golgi. Our results obtained with C127 mouse cells demonstrated that acidic amino acids (and serine) increased E5 transforming activity, whereas basic amino acids greatly inhibited E5 activity. Nonpolar amino acid substitutions were also defective. Interestingly, the relative transforming activities of these E5 mutant proteins changed dramatically when assayed with NIH 3T3 cells, suggesting that an auxiliary cellular protein(s) may modulate E5 transformation or that there are additional or different mechanisms of E5 transformation which are utilized in these two cell lines.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8057494      PMCID: PMC237025     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Transforming activity of a 16-amino-acid segment of the bovine papillomavirus E5 protein linked to random sequences of hydrophobic amino acids.

Authors:  B H Horwitz; D L Weinstat; D DiMaio
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

2.  44-amino-acid E5 transforming protein of bovine papillomavirus requires a hydrophobic core and specific carboxyl-terminal amino acids.

Authors:  B H Horwitz; A L Burkhardt; R Schlegel; D DiMaio
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

3.  Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization.

Authors:  A Mincheva; L Gissmann; H zur Hausen
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

4.  E5 open reading frame of bovine papillomavirus type 1 encodes a transforming gene.

Authors:  J T Schiller; W C Vass; K H Vousden; D R Lowy
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

5.  Translation of open reading frame E5 of bovine papillomavirus is required for its transforming activity.

Authors:  D DiMaio; D Guralski; J T Schiller
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

6.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

7.  Genetic analysis of the 3' early region transformation and replication functions of bovine papillomavirus type 1.

Authors:  D E Groff; W D Lancaster
Journal:  Virology       Date:  1986-04-15       Impact factor: 3.616

8.  The E5 transforming gene of bovine papillomavirus encodes a small, hydrophobic polypeptide.

Authors:  R Schlegel; M Wade-Glass; M S Rabson; Y C Yang
Journal:  Science       Date:  1986-07-25       Impact factor: 47.728

9.  Platelet-derived growth factor receptor can mediate tumorigenic transformation by the bovine papillomavirus E5 protein.

Authors:  L A Nilson; D DiMaio
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

10.  Genetic and biochemical definition of the bovine papillomavirus E5 transforming protein.

Authors:  A Burkhardt; D DiMaio; R Schlegel
Journal:  EMBO J       Date:  1987-08       Impact factor: 11.598

View more
  18 in total

1.  The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification.

Authors:  Frank A Suprynowicz; Ewa Krawczyk; Jess D Hebert; Sawali R Sudarshan; Vera Simic; Christopher M Kamonjoh; Richard Schlegel
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

2.  The canine papillomavirus e5 protein signals from the endoplasmic reticulum.

Authors:  Rachel Condjella; Xuefeng Liu; Frank Suprynowicz; Hang Yuan; Sawali Sudarshan; Yuhai Dai; Richard Schlegel
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

3.  Membrane orientation of the human papillomavirus type 16 E5 oncoprotein.

Authors:  Ewa Krawczyk; Frank A Suprynowicz; Sawali R Sudarshan; Richard Schlegel
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

4.  Mutational analysis of the interaction between the bovine papillomavirus E5 transforming protein and the endogenous beta receptor for platelet-derived growth factor in mouse C127 cells.

Authors:  L A Nilson; R L Gottlieb; G W Polack; D DiMaio
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

5.  Serum- and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16.

Authors:  L Sherman; R Schlegel
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

6.  Identification of amino acids in the transmembrane and juxtamembrane domains of the platelet-derived growth factor receptor required for productive interaction with the bovine papillomavirus E5 protein.

Authors:  L M Petti; V Reddy; S O Smith; D DiMaio
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

7.  Endoplasmic reticulum-localized human papillomavirus type 16 E5 protein alters endosomal pH but not trans-Golgi pH.

Authors:  Gary L Disbrow; John A Hanover; Richard Schlegel
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

8.  Karyopherin beta3: a new cellular target for the HPV-16 E5 oncoprotein.

Authors:  Ewa Krawczyk; John A Hanover; Richard Schlegel; Frank A Suprynowicz
Journal:  Biochem Biophys Res Commun       Date:  2008-05-01       Impact factor: 3.575

Review 9.  The bovine papillomavirus E5 protein and the PDGF beta receptor: it takes two to tango.

Authors:  Kristina Talbert-Slagle; Daniel DiMaio
Journal:  Virology       Date:  2008-11-06       Impact factor: 3.616

10.  E5 oncoprotein transmembrane mutants dissociate fibroblast transforming activity from 16-kilodalton protein binding and platelet-derived growth factor receptor binding and phosphorylation.

Authors:  J Sparkowski; M Mense; J Anders; R Schlegel
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.